Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2023-05-12 00:00:00 ET · period of report 2023-05-10 · accession 0001209191-23-028993 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-05-12 | 2023-05-10+ | TVTX | Calvin Sandra | SVP, CAO | S - Sale | $16.49 | -558 | 42.4K | -1% | -$9,200 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-11 | S | D | 122 | $16.12 | 42,247 | D | — | — | |
| 2 | Common | Common Stock | 2023-05-10 | S | D | 436 | $16.59 | 42,369 | D | — | — |